FTV vs SHC
FTV: Fortive provides mission-critical hardware, software, and workflow solutions that enhance safety, productivity, and operational efficiency in industrial and healthcare sectors worldwide. SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies.
Side-by-side fundamentals
| Metric | FTV | SHC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $60.25 | $17.29 | |
| Market cap as of 2026-07-23 | $18.4B | $4.9B | |
| P/E as of 2026-07-23 | 33.84 | 41.86 | FTV lower |
| PEG as of 2026-07-23 | n/a | 3.82 | |
| Net margin as of 2026-07-23 | +11.5% | +9.9% | FTV higher |
| Gross margin as of 2026-07-23 | +61.8% | +55.3% | FTV higher |
| Operating margin as of 2026-07-23 | +16.9% | +29.0% | SHC higher |
| ROE as of 2026-07-23 | +7.4% | +20.6% | SHC higher |
| ROA as of 2026-07-23 | +4.1% | +3.6% | FTV higher |
| Debt / equity as of 2026-07-23 | 0.57 | 3.59 | FTV lower |
| Revenue growth (YoY) as of 2026-07-23 | -23.4% | +7.4% | SHC higher |
| Revenue CAGR (3y) SEC XBRL | -10.6% | +5.1% | SHC higher |
| Dividend yield as of 2026-07-23 | +0.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 1.05 | 1.78 | |
| 1-year return as of 2026-07-22 close | +21.0% | +52.2% | SHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.